Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective
This is the first Australian study describing PSC and IBD PRO in a well-characterised prospective cohort. We have demonstrated that PSC-related PRO is significantly associated with liver disease severity. Further large-scale studies are required to further interrogate these findings.
Authors
- Stuart Keith Roberts (ORCID: https://orcid.org/0000-0002-9015-7997)
- Avik Majumdar (ORCID: https://orcid.org/0000-0003-2975-4327)
- Amanda Nicoll (ORCID: https://orcid.org/0000-0002-1855-2757)
- Kate Collins (ORCID: https://orcid.org/0000-0001-6357-3867)
- Nicholas Hannah (ORCID: https://orcid.org/0000-0002-1146-4308)
- Kate D. Lynch (ORCID: https://orcid.org/0000-0001-7748-2165)
- Christopher Zampogna
- Rohit Sawhney (ORCID: https://orcid.org/0000-0002-8131-2182)
- John Lubel (ORCID: https://orcid.org/0000-0003-0828-0572)
- Siddharth Sood (ORCID: https://orcid.org/0000-0002-5673-659X)
- Natassia Tan (ORCID: https://orcid.org/0000-0002-0967-3282)
- Andrew Coulshed (ORCID: https://orcid.org/0000-0002-1316-2768)
- Ammar Majeed (ORCID: https://orcid.org/0000-0002-7024-8787)
- Ken Liu (ORCID: https://orcid.org/0000-0002-0453-3168)
- William Kemp (ORCID: https://orcid.org/0000-0002-1891-4578)
- Stephen R. Bloom
Institutions
- Royal Adelaide Hospital (AU)
- The University of Melbourne (AU)
- Royal Prince Alfred Hospital (AU)
- The Alfred Hospital (AU)
- Eastern Health (AU)
- Melbourne Health (AU)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-03-02
- DOI
- https://doi.org/10.1111/apt.70054
- Citations
- 4
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 5.29
Funders
- Dr. Falk Pharma